Urinary tract infection (UTI) in postmenopausal women with type 2 diabetes mellitus using sodium- glucose co transporter 2 inhibitors (SGLT-2 I) | [Journal of Medical Science • 2024]

Author(s):

1. Muhammad Ubaid: Department of Diabetes and Endocrinology, MTI Lady Reading Hospital,Peshawar -,Pakistan

2. Sohrab Khan: Department of Diabetes and Endocrinology, MTI Lady Reading Hospital,Peshawar -,Pakistan

3. Nauman Wazir: Department of Diabetes and Endocrinology, MTI Lady Reading Hospital,Peshawar -,Pakistan

4. Irfan Ullah: Department of Diabetes and Endocrinology, MTI Lady Reading Hospital,Peshawar -,Pakistan

5. Mujeeb ur Rehman: Department of Diabetes and Endocrinology, MTI Lady Reading Hospital,Peshawar -,Pakistan

6. Ibrar Ahmed: Department of Diabetes and Endocrinology, MTI Lady Reading Hospital,Peshawar -,Pakistan

Abstract:

Objective: To determine the frequency of urinary tract infection in postmenopausal women with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors. Material And Methods: This descriptive cross-sectional study was performed on 101 postmenopausal patients with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors. Samples of blood and urine were sent to the hospital laboratory for analysis. Data was analyzed using SPSS version 20. The Chi-square test was performed after stratification. RESULTS: The mean and standard deviation for age was 60.9±4.4. 24.8% of post-menopausal women with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors were having urinary tract infections. The majority of these patients were illiterate or had primary education and the duration of diabetes was more than 10 years. Conclusion: Urinary tract infection is a common problem in postmenopausal women with type 2 diabetes mellitus using sodium-glucose co-transporter 2 inhibitors. Patients with poorly controlled diabetes and increased duration of menopause have an increased risk of urinary tract infection.

Page(s): 143-146

DOI: 10.52764/jms.24.32.2.5

Published: Journal: Journal of Medical Science, Volume: 32, Issue: 2, Year: 2024

Keywords:

Urinary Tract Infection UTI , Postmenopausal , type 2 diabetes mellitus DM , sodiumglucose cotransporter 2 inhibitors SGLT2Is

References:

[1] Galicia-Garcia U,Benito-Vicente A,Jebari S,Larrea-Sebal A,Siddiqi H,Uribe KB .2020 .Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 21 : 6275.

[2] Jafar N,Edriss H,Nugent K. . .The effect of short-term hyperglycemia on the innate immune system. The American journal of the medical sciences. 2016 Feb, 1(2) : 201-11.

[3] Casqueiro J,Casqueiro J,Alves C. . .Infections in patients with diabetes mellitus: A review of pathogenesis. Indian journal of endocrinology and metabolism, 16 : S27.

[4] . .Retrospective analysis of antibiotic resistance pattern to commonly used anti bacterials. 2015 Jun, 20(2) : 333-7.

[5] Aliyu S,Cohen B,Liu J,Larson E .2018 .Prevalence and risk factors for bloodstream infection present on hospital admission. Journal of Infection Prevention, 19(1) : 37-42.

[6] de Lastours V,Foxman B . .Urinary tract infection in diabetes: epidemiologic considerations. 2014 Jan;16, (1) : 1-6.

[7] Papadopoulou SA,Kaski JC . .Ischaemic heart disease in the aging woman. Best Practice & Research Clinical Obstetrics & Gynaecology. 2013 Oct, 1(5) : 689-97.

[8] Dosi R,Bhatt N,Shah P,Patell R . .Cardiovascular disease and menopause. Journal of clinical and diagnostic research: JCDR. 2014 Feb;8, (2) : 62.

[9] McGuire DK,Shih WJ,Cosentino F,Charbonnel B,Cherney DZ,Dagogo-Jack S,Pratley R,Greenberg M,Wang S,Huyck S,Gantz I. . .Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis. 2021 Feb, 1(2) : 148-58.

[10] Liu H,Sridhar VS,Boulet J,Dharia A,Khan A,Lawler PR,Cherney DZ . .Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease. Metabolism. 2022 Jan, 1 : 154918.

[11] Das B,Sheikh A,Ahmed B,Islam N. .2021 .Clinical outcomes of Sodium-glucose cotransporter-2 inhibitors in patients with Type 2 Diabetes Mellitus: An observational study from Pakistan. Pakistan Journal of Medical Sciences, 37(5) : 1342.

[12] Borowczyk M,Chmielarz-Czarnocińska A,Faner-Szczepańska P,Paciorkowski A,Nowak JK,SzczepanekParulska E,Ruchała M,Cymerys M. . .Urinary tract infections in postmenopausal women with type 2 diabetes: clinical correlates and quinolone susceptibility. 2017 May, 5(5) : 336-42.

[13] Khan S,Hashmi MS,Rana MA,Zafar GM,Asif S,Farooq MT,Zahoor S,Hashmi M . .Asif Sr S. Frequency of urinary tract infections in type 2 diabetic patients taking dapaglilfozin. Cureus. 2022 Jan, 29(1) : .

[14] Uitrakul S,Aksonnam K,Srivichai P,Wicheannarat S,Incomenoy S. . .The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study. Medicines, 9(12) : 59.

[15] Li D,Wang T,Shen S,Fang Z,Dong Y,Tang H Y . .Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of randomized controlled trials. Diabetes, Obesity and Metabolism, 19(3) : 348-55.

[16] Rizzi M,Trevisan R,Diseases Cardiovascular . .Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors. 2016 Nov, 1(11) : 963-70.

Citations

Downloads

Views